Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Hospital Pediatrics|August 23, 2023
FeBRILe3: Safety Evaluation of Febrile Infant Guidelines Through Prospective Bayesian MonitoringAriel O Mace, James Totterdell, Andrew C Martin, et al.
The Lancet Regional Health. Western Pacific|March 6, 2026
The AuTOMATIC trial: a multicentre digitally-automated, Bayesian, adaptive, parallel, factorial randomised controlled trial of SMS reminders for childhood vaccinationGrace Currie, James Totterdell, Claire S Waddington, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 8, 2024
TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of randomized clinical trials of nafamostat and camostat mesylateMaría Patricia Hernández-Mitre, Susan C Morpeth, Balasubramanian Venkatesh, et al.
BMC Health Services Research|April 13, 2019
Can a continuous quality improvement program create culturally safe emergency departments for Aboriginal people in Australia? A multiple baseline studyThomas Gadsden, Gai Wilson, James Totterdell, et al.
Trials|June 16, 2026
ORIGIN-1 trial: study protocol for an organoid-guided N-of-1 trial evaluating CFTR modulator response in cystic fibrosis with rare non-F508del mutationsLorena Rodrigues Sabino, Gerard E Kaiko, Douglas Dorahy, et al.
BMJ Open|December 18, 2020
OPTIMUM study protocol: an adaptive randomised controlled trial of a mixed whole-cell/acellular pertussis vaccine scheduleGladymar Perez Chacon, Marie J Estcourt, James Totterdell, et al.
BMJ Open|October 22, 2024
Combination of the chemokine receptor type 2 (CCR2) antagonist DMX-200 and candesartan for COVID-19: a randomised controlled trialDaniel Vincent O'Hara, Abhinav Bassi, Arlen Wilcox, et al.
Trials|December 13, 2022
ASCOT ADAPT study of COVID-19 therapeutics in hospitalised patients: an international multicentre adaptive platform trialJustin T Denholm, Balasubramanian Venkatesh, Joshua Davis, et al.
Plos Medicine|June 10, 2024
Immunogenicity, reactogenicity, and IgE-mediated immune responses of a mixed whole-cell and acellular pertussis vaccine schedule in Australian infants: A randomised, double-blind, noninferiority trialGladymar Pérez Chacón, Marie J Estcourt, James Totterdell, et al.
The Journal of Infection|May 25, 2025
Immune impacts of infant whole-cell and acellular pertussis vaccination on co-administered vaccinesGladymar Pérez Chacón, Sonia McAlister, James Totterdell, et al.
Pageof 3